FibroGen FGEN reported its Q4 earnings results on Monday, February 26, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
FibroGen missed estimated earnings by -36.0%, reporting an EPS of $-0.57 versus an estimate of $-0.42.
Revenue was down $7.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.16 which was followed by a 1.0% drop in the share price the next day.
Here's a look at FibroGen's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | -0.68 | -0.72 | -0.75 | -0.94 |
EPS Actual | -0.52 | -0.90 | -0.81 | -0.70 |
Revenue Estimate | 36.84M | 34.17M | 31.84M | 24.04M |
Revenue Actual | 40.13M | 44.32M | 36.16M | 34.37M |
To track all earnings releases for FibroGen visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.